Johnson & Johnson to Participate in the Morgan Stanley 21st Annual Global Healthcare Conference
August 22 2023 - 10:24AM
Business Wire
Johnson & Johnson (NYSE: JNJ) will participate in the Morgan
Stanley 21st Annual Global Healthcare Conference at the Sheraton
New York Hotel in New York on Wednesday, September 13th. Joaquin
Duato, Chairman of the Board and Chief Executive Officer and John
Reed, Executive Vice President Pharmaceuticals R&D will
represent the Company in a session scheduled at 10:10 a.m. (Eastern
Time).
This conference call will be available to investors and other
interested parties by visiting the Johnson & Johnson website at
www.investor.jnj.com.
A webcast and podcast replay will be available approximately 48
hours after the live webcast.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20230822087768/en/
Investor Contact: investor-relations@its.jnj.com
Media Contact: media-relations@its.jnj.com
Johnson and Johnson (NYSE:JNJ)
Historical Stock Chart
From Oct 2024 to Nov 2024
Johnson and Johnson (NYSE:JNJ)
Historical Stock Chart
From Nov 2023 to Nov 2024